AKT inhibitor VIII
CAS: 612847-09-3
Ref. TM-T3346
| 1mg | 52.00 € | ||
| 2mg | 66.00 € | ||
| 5mg | 103.00 € | ||
| 10mg | 149.00 € | ||
| 25mg | 259.00 € | ||
| 50mg | 425.00 € | ||
| 100mg | 627.00 € | ||
| 1mL*10mM (DMSO) | 126.00 € |
Estimated delivery in United States, on Friday 22 Nov 2024
Product Information
Name:
AKT inhibitor VIII
Synonyms:
- AKTi-1/2
- 1-{1-[4-(7-phenyl-1H-imidazo[4,5-g]quinoxalin-6-yl)benzyl]piperidin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one
- 2H-benzimidazol-2-one, 1,3-dihydro-1-[1-[[4-(7-phenyl-1H-imidazo[4,5-g]quinoxalin-6-yl)phenyl]methyl]-4-piperidinyl]-
Description:
AKT inhibitor VIII (AKTi-1/2) is a highly specific Akt1/2 inhibitor (IC50: 58/210 nM). The selectivity for Akt1 is higher about 36-fold than Akt3.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Molecular weight:
551.64
Formula:
C34H29N7O
Purity:
98.65% - 98.77%
Color/Form:
Pale Yellow Solid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T3346 AKT inhibitor VIII
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
